The Legal 500: Pharmaceutical Advertising Country Comparative Guide 2023

Published

Dec 12 2023

Written By

Senior Associate
UK

I am a senior associate in the Intellectual Property Group in London, with a focus on regulatory and commercial matters primarily in the life sciences and healthcare sectors.

Sally Shorthose

Partner
UK

As one of our firm's most experienced intellectual property partners, specialising in transactional IP matters, I offer a wealth of knowledge to businesses at the cutting edge of research, development and technology, in a variety of sectors for which IP is of prime importance.

Sectors

Life Sciences and Healthcare

Regions

Western Europe

Countries

The latest edition of the Legal 500: Pharmaceutical Advertising Comparative Guide is now online. The aim of this guide is to provide its readers with a pragmatic overview of the law and practice of pharmaceutical advertising law across a variety of jurisdictions.

Each chapter of this guide provides information about the current issues affecting pharmaceutical advertising in a particular country and addresses topics such as self-regulation, press releases, gifts, samples, grants or donations, anti-bribery rules, regulatory authorities and courts, as well as insight and opinion on the most common issues in their respective country.

The Q&A template for each chapter has been provided by Sally Shorthose.

We have written the UK chapter of the guide which provides an overview of the pharmaceutical advertising laws and regulations applicable in the UK.

Download the UK chapter here